Niccolette Schaunaman

Experienced Laboratory Manager with expertise in designing and optimizing experiments and interpreting findings. Seeking new challenges to positively impact laboratory operations and research success. Committed to utilizing leadership skills to drive innovation, improve efficiency, and uphold quality standards in scientific research.

• Schaunaman N, Nichols T, Cervantes D, Hartsoe P, Ferrington DA, Chu HW. (2024). “The effect of a TLR3 agonist on airway allergic inflammation and viral infection in immunoproteasome-deficient mice.” Viruses.
• Schaunaman N, Cervantes D, Nichols T, Numata M, Ledford JG, Kraft M, Chu HW. (2024). “Cooperation of immune regulators Tollip and surfactant protein A inhibits influenza A virus infection in mice.” Respir Res.
• Schaunaman N, Dimasuay KG, Cervantes D, Li L, Numata M, Kraft M, Chu HW. (2023). “Tollip inhibits IL-33 release and inflammation in influenza A virus-infected mouse airways.” J Innate Immun.
• Schaunaman N, Dimasuay KG, Berg B, Cervantes D, Chu HW. (2022) “Human bronchial epithelial cell culture models for cigarette smoke and vaping studies.” Methods Mol Biol.
• Schaunaman N, Crue T, Cervantes D, Schweitzer K, Robbins H, Day BJ, Numata M, Petrache I, Chu HW. (2022). “Electronic cigarette vapor exposure exaggerates the pro-inflammatory response during influenza A viral infection in human distal airway epithelium.” Arch Toxicol.
• Schaunaman N, Dimasuay KG, Kraft M, Chu HW. (2022). “Tollip interaction with STAT3: a novel mechanism to regulate human airway epithelial responses to type 2 cytokines.” Respir Res.
• Schaunaman N, Sanchez A, Dimasuay KG, Pavelka N, Numata M, Alam R, Martin RJ, Chu HW. (2019). “Interleukin 1 Receptor-Like 1 (IL1RL1) Promotes Airway Bacterial and Viral Infection and Inflammation.” Infect Immun.
• Schaefer N, Li X, Seibold MA, Jarjour NN, Denlinger LC, Castro M, Coverstone AM, Teague WG, Boomer J, Bleecker ER, Meyers DA, Moore WC, Hawking GA, Fahy J, Phillips BR, Mauger DT, Dakhama A, Gellatly S, Pavelka N, Berman R, Di YP, Wenzel SE, Chu HW. (2019). “The effect of BPIFA1/SPLUNC1 genetic variation on its expression and function in asthmatic airway epithelium.” JCI insight.

February 2025 - National Jewish Health Research Retreat

My submitted abstract “Degradation of IL-4Ralpha by immunoproteasome: implication in airway type 2 inflammation and hyperresponsiveness” was selected as one of two winners to present my data to the research community at National Jewish Health.

February 2022 - National Jewish Health Research Retreat

My submitted abstract “Immunoproteasome inhibits allergic inflammation and airway hyperresponsiveness during rhinovirus infection” was selected as one of two winners to present my data to the research community at National Jewish Health.